{"id":"dysport-injectable-product","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Injection site pain or bruising"},{"rate":"5-15","effect":"Headache"},{"rate":"1-5","effect":"Muscle weakness or paralysis (off-target)"},{"rate":"1-3","effect":"Ptosis (eyelid drooping)"},{"rate":"5-10","effect":"Antibody formation (neutralizing antibodies)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dysport contains botulinum toxin type A, which cleaves SNARE proteins required for acetylcholine vesicle fusion and release. This results in temporary denervation and muscle relaxation at the injection site. The effect is localized and reversible, typically lasting 3-4 months before neuromuscular function gradually recovers.","oneSentence":"Dysport is a botulinum toxin type A preparation that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:10:30.129Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cervical dystonia"},{"name":"Blepharospasm"},{"name":"Hemifacial spasm"},{"name":"Glabellar lines (wrinkles)"},{"name":"Hyperhidrosis (excessive sweating)"}]},"trialDetails":[{"nctId":"NCT06783621","phase":"PHASE4","title":"A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products","status":"COMPLETED","sponsor":"AbbVie","startDate":"2025-01-16","conditions":"Facial Contouring","enrollment":130},{"nctId":"NCT07478822","phase":"PHASE3","title":"A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity","status":"RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2026-03-20","conditions":"Upper Limb Spasticity","enrollment":300},{"nctId":"NCT07388927","phase":"PHASE4","title":"A Real-World Study on Effect of Hirudoid on Ecchymosis After Treatment of Crow's Feet With Botulinum Toxin Type A","status":"NOT_YET_RECRUITING","sponsor":"DKSH Management (Thailand) Limited","startDate":"2026-02","conditions":"Ecchymosis After Periorbital Rejuvenation With Botulinum Toxin Type A, Crow's Feet Lines, Lateral Canthal Lines, LCL","enrollment":48},{"nctId":"NCT07385742","phase":"NA","title":"Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement","status":"COMPLETED","sponsor":"Suez Canal University","startDate":"2024-01-10","conditions":"Temporomandibular Joint Internal Derangement, Temporomandibular Joint Disorders, Temporomandibular Disorders (TMD)","enrollment":20},{"nctId":"NCT06585696","phase":"PHASE3","title":"A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)","status":"COMPLETED","sponsor":"Cutia Therapeutics（Wuxi）Co.,Ltd","startDate":"2024-06-11","conditions":"Glabellar Frown Lines","enrollment":554},{"nctId":"NCT07369453","phase":"NA","title":"Exercise to Improve Sleep and Quality of Life in Stroke Patients Receiving Botulinum Toxin Treatment","status":"COMPLETED","sponsor":"Bursa Yuksek Ihtisas Training and Research Hospital","startDate":"2021-09-15","conditions":"Hemiplegia and/or Hemiparesis Following Stroke","enrollment":56},{"nctId":"NCT07360483","phase":"NA","title":"Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-01-01","conditions":"Hypertrophic Scars","enrollment":48},{"nctId":"NCT06216886","phase":"PHASE4","title":"OnabotulinumtoxinA for Trigeminal Neuralgia","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-06-01","conditions":"Trigeminal Neuralgia","enrollment":20},{"nctId":"NCT06783114","phase":"PHASE2, PHASE3","title":"A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults","status":"RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2024-09-14","conditions":"Upper Limb Spasticity","enrollment":254},{"nctId":"NCT02414425","phase":"PHASE3","title":"Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-11-25","conditions":"Fecal Incontinence","enrollment":200},{"nctId":"NCT06070987","phase":"NA","title":"Exoskeleton Robotic Assisted Gait Training in Spastic Stroke Post Botulinum Toxin A Injection","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2023-08-01","conditions":"Spastic Gait, Spastic","enrollment":30},{"nctId":"NCT06899438","phase":"NA","title":"Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not","status":"COMPLETED","sponsor":"Bursa City Hospital","startDate":"2009-08-26","conditions":"Myofacial Pain Syndromes","enrollment":38},{"nctId":"NCT07270042","phase":"NA","title":"Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection","status":"NOT_YET_RECRUITING","sponsor":"Tishreen University","startDate":"2025-12-01","conditions":"Hyperactive Masseter Muscle","enrollment":20},{"nctId":"NCT07268261","phase":"NA","title":"Combined Method of Surgical Treatment of Anal Fissure","status":"RECRUITING","sponsor":"State Scientific Centre of Coloproctology, Russian Federation","startDate":"2023-09-01","conditions":"Chronic Anal Fissure","enrollment":122},{"nctId":"NCT07242300","phase":"PHASE3","title":"Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .","status":"NOT_YET_RECRUITING","sponsor":"JHM BioPharma (Tonghua) Co. , Ltd.","startDate":"2026-01","conditions":"Upper Limb Spasticity (ULS)","enrollment":207},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188},{"nctId":"NCT07236632","phase":"NA","title":"Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study","status":"NOT_YET_RECRUITING","sponsor":"Benha University","startDate":"2025-12-15","conditions":"Premature Ejaculation","enrollment":80},{"nctId":"NCT05330078","phase":"EARLY_PHASE1","title":"Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2022-03-11","conditions":"Keloid","enrollment":10},{"nctId":"NCT05123053","phase":"PHASE2","title":"Firdapse for Post-BOTOX Vocal Weakness","status":"COMPLETED","sponsor":"Augusta University","startDate":"2021-10-28","conditions":"Vocal Weakness(Post-BOTOX Injection)","enrollment":18},{"nctId":"NCT05806164","phase":"PHASE4","title":"Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2023-06-06","conditions":"Urgency Urinary Incontinence","enrollment":432},{"nctId":"NCT06796985","phase":"PHASE1","title":"Botox for Chronic Pelvic Pain","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-02-24","conditions":"Pelvic Floor Disorders","enrollment":30},{"nctId":"NCT07072806","phase":"PHASE4","title":"A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2022-06-14","conditions":"Forehead Rhytides","enrollment":20},{"nctId":"NCT05089357","phase":"","title":"Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2021-11-11","conditions":"Glabellar Lines","enrollment":250},{"nctId":"NCT04609020","phase":"PHASE4","title":"Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment","status":"COMPLETED","sponsor":"Allergan","startDate":"2023-02-15","conditions":"Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality","enrollment":64},{"nctId":"NCT07025642","phase":"NA","title":"Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes","status":"RECRUITING","sponsor":"Mackay Medical College","startDate":"2025-07-01","conditions":"Overactive Bladder (OAB)","enrollment":60},{"nctId":"NCT07013279","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines","status":"NOT_YET_RECRUITING","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2025-07-15","conditions":"Glabellar Lines","enrollment":324},{"nctId":"NCT04171531","phase":"PHASE3","title":"Sling vs Botox for Mixed Incontinence","status":"COMPLETED","sponsor":"NICHD Pelvic Floor Disorders Network","startDate":"2020-06-08","conditions":"Urinary Incontinence, Stress, Urinary Incontinence, Urge","enrollment":150},{"nctId":"NCT04075981","phase":"PHASE3","title":"Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-30","conditions":"Cardiac Surgery","enrollment":220},{"nctId":"NCT05968885","phase":"PHASE4","title":"Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2021-10-01","conditions":"Urinary Bladder, Overactive, Urodynamics, Effect of Drug","enrollment":300},{"nctId":"NCT06953271","phase":"PHASE4","title":"Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection","status":"NOT_YET_RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-15","conditions":"Overactive Bladder (OAB), Urinary Tract Infection (Diagnosis)","enrollment":164},{"nctId":"NCT02677805","phase":"PHASE3","title":"Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2016-03-30","conditions":"Glabellar Frown Lines","enrollment":251},{"nctId":"NCT04763265","phase":"PHASE2","title":"Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2020-06-24","conditions":"Frown Lines","enrollment":208},{"nctId":"NCT06778421","phase":"PHASE1","title":"Impact of OnabotulinumtoxinA (BOTOX®) on Stress","status":"RECRUITING","sponsor":"Center for Advanced Facial Plastic Surgery","startDate":"2025-01-20","conditions":"Stress (Psychology), Stress, Healthy Adult Female Participants","enrollment":20},{"nctId":"NCT06793683","phase":"EARLY_PHASE1","title":"Early BOTOX After Spinal Cord Injury","status":"ENROLLING_BY_INVITATION","sponsor":"University of Washington","startDate":"2024-07-27","conditions":"Spinal Cord Injuries","enrollment":10},{"nctId":"NCT05167864","phase":"NA","title":"Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2022-03-04","conditions":"Cosmetic Techniques","enrollment":143},{"nctId":"NCT04755595","phase":"PHASE2","title":"Combination Facial Aesthetic Treatment in Millennials","status":"COMPLETED","sponsor":"State University of New York - Downstate Medical Center","startDate":"2021-03-09","conditions":"Dermatological Non-Disease","enrollment":20},{"nctId":"NCT06729840","phase":"PHASE3","title":"Intralesional Treatment of Keloids","status":"RECRUITING","sponsor":"Sohag University","startDate":"2024-12-01","conditions":"Scar, Hypertrophic","enrollment":45},{"nctId":"NCT04630873","phase":"PHASE1","title":"Low or High Botox Dilution for the Hemiplegic Gait?","status":"RECRUITING","sponsor":"University of Ioannina","startDate":"2020-11-20","conditions":"Post Stroke Spastic Hemiplegia","enrollment":20},{"nctId":"NCT05072821","phase":"PHASE4","title":"Botulinum Toxin Type a Injection to Prevent Keloid Recurrence","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-10-13","conditions":"Scar Keloid","enrollment":28},{"nctId":"NCT05698979","phase":"PHASE3","title":"Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-01-01","conditions":"Buerger Disease, Raynaud Syndrome","enrollment":8},{"nctId":"NCT06583486","phase":"PHASE3","title":"A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2024-03-19","conditions":"Moderate to Severe Glabellar Lines","enrollment":488},{"nctId":"NCT01177358","phase":"PHASE2","title":"Botox in the Healing of Surgical Wounds of the Neck","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2010-05-31","conditions":"Scar","enrollment":40},{"nctId":"NCT06562023","phase":"NA","title":"Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring","status":"COMPLETED","sponsor":"Hams Hamed Abdelrahman","startDate":"2022-11-19","conditions":"Facial Scars","enrollment":33},{"nctId":"NCT06499688","phase":"PHASE3","title":"A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2023-12-28","conditions":"Moderate to Severe Glabellar Lines","enrollment":529},{"nctId":"NCT06203470","phase":"PHASE4","title":"Botox Versus Tacrolimus in Psoriasis Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-06","conditions":"Psoriasis Vulgaris","enrollment":60},{"nctId":"NCT05284019","phase":"PHASE4","title":"Real World Effectiveness of Eptinezumab in Participants With Migraine","status":"TERMINATED","sponsor":"H. Lundbeck A/S","startDate":"2022-03-04","conditions":"Migraine","enrollment":32},{"nctId":"NCT04754737","phase":"NA","title":"Antibiotic Usage Prior to OnabotulinumtoxinA Injection","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2021-03-23","conditions":"Antibiotic Stewardship, Overactive Bladder, Onabotulinumtoxin A","enrollment":200},{"nctId":"NCT06213662","phase":"NA","title":"Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2022-11-01","conditions":"Cricopharyngeal Achalasia, Dysphagia","enrollment":20},{"nctId":"NCT06196606","phase":"NA","title":"Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2022-11-11","conditions":"Brain Stem Infarctions, Dysphagia, Oropharyngeal, Dysphagia, Esophageal","enrollment":20},{"nctId":"NCT05485207","phase":"EARLY_PHASE1","title":"Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2022-04-04","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":5},{"nctId":"NCT04124939","phase":"PHASE4","title":"Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-11-10","conditions":"Overactive Bladder","enrollment":41},{"nctId":"NCT06354127","phase":"PHASE3","title":"DWP450 for Treating Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2020-08-12","conditions":"Moderate to Severe Glabellar Lines","enrollment":473},{"nctId":"NCT06328556","phase":"NA","title":"Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"Copka Sonpashan","startDate":"2024-03","conditions":"Cricopharyngeal Achalasia","enrollment":30},{"nctId":"NCT04502264","phase":"PHASE2","title":"Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox Injections","status":"COMPLETED","sponsor":"Cheng-Hsin General Hospital","startDate":"2020-01-09","conditions":"Chronic Stroke, Spasticity as Sequela of Stroke, Robotic Rehabilitation","enrollment":24},{"nctId":"NCT06282679","phase":"NA","title":"Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-04-01","conditions":"Rosacea, Botulinum Toxin","enrollment":30},{"nctId":"NCT06225024","phase":"NA","title":"Efficacy of Extracorporeal Shock Wave Therapy on Spasticity","status":"COMPLETED","sponsor":"Kayseri City Hospital","startDate":"2022-03-15","conditions":"Stroke, Spasticity, Muscle","enrollment":40},{"nctId":"NCT04383912","phase":"NA","title":"Onabotulinum Toxin A in Direct Brow Lift","status":"UNKNOWN","sponsor":"Nova Scotia Health Authority","startDate":"2020-11-18","conditions":"Direct Brow Lift, Scarring","enrollment":16},{"nctId":"NCT06230146","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-05-01","conditions":"Keloid","enrollment":45},{"nctId":"NCT06207955","phase":"NA","title":"I-PRF After Arthrocentesis Plus Botox Injection to Lateral Pterygoid Muscle in Treatment of Anterior Disc Displacement","status":"UNKNOWN","sponsor":"Fayoum University","startDate":"2024-02","conditions":"TMJ Disc Disorder, TMJ Pain","enrollment":39},{"nctId":"NCT05719285","phase":"PHASE4","title":"Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2022-12-06","conditions":"Overactive Bladder, Overactive Bladder Syndrome, Urge Incontinence","enrollment":100},{"nctId":"NCT03508921","phase":"PHASE4","title":"Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-07-01","conditions":"Overactive Bladder, Urinary Tract Infections","enrollment":22},{"nctId":"NCT03712449","phase":"PHASE4","title":"A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-01-22","conditions":"Facial Rhytides, Skin Folds, Loss of Volume and Skin Quality","enrollment":59},{"nctId":"NCT04922983","phase":"PHASE2","title":"Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis","status":"UNKNOWN","sponsor":"Manhattan Physical Medicine and Rehabilitation, LLP","startDate":"2021-07-01","conditions":"Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis; Lumbar Region","enrollment":42},{"nctId":"NCT06034288","phase":"PHASE2","title":"Xeomin vs Botox for Treatment of Overactive Bladder Syndrome","status":"UNKNOWN","sponsor":"Walter Reed National Military Medical Center","startDate":"2023-05-04","conditions":"Overactive Bladder Syndrome","enrollment":64},{"nctId":"NCT04401176","phase":"PHASE2","title":"Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome","status":"COMPLETED","sponsor":"Walter Reed National Military Medical Center","startDate":"2020-09-15","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":58},{"nctId":"NCT03821402","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-12-12","conditions":"Upper Limb Spasticity","enrollment":83},{"nctId":"NCT03825315","phase":"PHASE2","title":"DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-12-31","conditions":"Plantar Fasciitis","enrollment":155},{"nctId":"NCT04826900","phase":"NA","title":"Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-08-01","conditions":"Hemiplegia, Spastic, Spastic","enrollment":31},{"nctId":"NCT06013644","phase":"EARLY_PHASE1","title":"Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-06-03","conditions":"Myofascial Trigger Point Pain, Myofascial Pain Syndrome","enrollment":39},{"nctId":"NCT03453632","phase":"PHASE2, PHASE3","title":"Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex","status":"UNKNOWN","sponsor":"University Hospital, Toulouse","startDate":"2018-06-14","conditions":"Epidermolysis Bullosa Simplex","enrollment":25},{"nctId":"NCT03911102","phase":"PHASE2","title":"Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2019-03-11","conditions":"Lateral Canthal Lines","enrollment":63},{"nctId":"NCT04259086","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2019-12-06","conditions":"Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)","enrollment":48},{"nctId":"NCT05891314","phase":"NA","title":"The Effect of Botulinum Toxin Injection After Hemorrhoidectomy in Pain Control.","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2021-12-01","conditions":"Pain, Haemorriodectomy, Anal Sphincterotomy","enrollment":60},{"nctId":"NCT05617118","phase":"","title":"BTA vs Baclofen for Pelvic Myofascial Pain Syndrome","status":"UNKNOWN","sponsor":"Saint Petersburg State University, Russia","startDate":"2022-12-01","conditions":"Chronic Pain, Chronic Pelvic Pain Syndrome, Myofascial Pain Syndrome","enrollment":52},{"nctId":"NCT03555916","phase":"PHASE3","title":"Botulinum Toxin Injections for Oral Neuropathic Pain","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-04-04","conditions":"Trigeminal Neuropathy, Traumatic","enrollment":43},{"nctId":"NCT02678377","phase":"PHASE4","title":"The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2016-02","conditions":"Mixed Urinary Incontinence, Stress Urinary Incontinence, Urgency Incontinence","enrollment":100},{"nctId":"NCT03786770","phase":"PHASE2","title":"Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2019-01-24","conditions":"Frown Lines","enrollment":61},{"nctId":"NCT03891680","phase":"NA","title":"Intra Articular Botox Injection in Treatment of Osteoarthritis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-10-20","conditions":"Osteoarthritis Knees Both","enrollment":60},{"nctId":"NCT02097121","phase":"PHASE3","title":"OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)","status":"TERMINATED","sponsor":"Allergan","startDate":"2014-05-23","conditions":"Urinary Incontinence, Urinary Bladder, Overactive","enrollment":56},{"nctId":"NCT05651256","phase":"PHASE2, PHASE3","title":"Efficacy of Botulinum Toxin in Temporomandibular Disorders","status":"COMPLETED","sponsor":"University of Salamanca","startDate":"2021-03-01","conditions":"Temporomandibular Joint Disorder Bilateral","enrollment":20},{"nctId":"NCT03608397","phase":"PHASE3","title":"Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-06-20","conditions":"Cervical Dystonia","enrollment":301},{"nctId":"NCT05615987","phase":"PHASE4","title":"Comparison of Botulinum Toxin Injection Techniques in Spasticity","status":"UNKNOWN","sponsor":"Konya Beyhekim Training and Research Hospital","startDate":"2022-12-01","conditions":"Spastic Hemiplegia","enrollment":60},{"nctId":"NCT02353871","phase":"PHASE3","title":"Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Ipsen","startDate":"2015-01","conditions":"Moderate to Severe Glabellar Lines","enrollment":185},{"nctId":"NCT01313312","phase":"PHASE3","title":"Dysport® Adult Upper Limb Spasticity Extension Study","status":"COMPLETED","sponsor":"Ipsen","startDate":"2011-11","conditions":"Nervous System Disorders","enrollment":258},{"nctId":"NCT05517538","phase":"NA","title":"Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique","status":"COMPLETED","sponsor":"Mohamed Hayder Oleish Salih","startDate":"2021-08-09","conditions":"Glabellar Frown Lines, Rhytides, Wrinkle","enrollment":15},{"nctId":"NCT02718118","phase":"PHASE4","title":"Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-04","conditions":"Glabellar Lines, Wrinkles","enrollment":60},{"nctId":"NCT05463822","phase":"EARLY_PHASE1","title":"Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-06-20","conditions":"Overactive Bladder, Bladder, Overactive, Urge Incontinence","enrollment":15},{"nctId":"NCT04270214","phase":"NA","title":"Conversion to Dysport in CD","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2020-06-01","conditions":"Cervical Dystonia","enrollment":33},{"nctId":"NCT03469999","phase":"PHASE3","title":"Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy","status":"COMPLETED","sponsor":"Columbia University","startDate":"2018-12-12","conditions":"Cerebral Palsy","enrollment":12},{"nctId":"NCT05380154","phase":"PHASE3","title":"Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.","status":"COMPLETED","sponsor":"Hugel","startDate":"2017-05-09","conditions":"Glabellar Lines","enrollment":500},{"nctId":"NCT00474032","phase":"NA","title":"Using Botox to Treat Patients With Idiopathic Clubfoot","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2003-03","conditions":"Clubfoot","enrollment":2000},{"nctId":"NCT02173405","phase":"PHASE1","title":"Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-08-01","conditions":"Myofascial Pain Syndromes, Myofascial Trigger Point Pain, Trigger Point Pain, Myofascial","enrollment":10},{"nctId":"NCT05162300","phase":"PHASE4","title":"Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles","status":"COMPLETED","sponsor":"Vitality Institute Medical Products","startDate":"2021-12-08","conditions":"Photoaging, Wrinkle, Sun Damaged Skin","enrollment":30},{"nctId":"NCT05296759","phase":"PHASE4","title":"Botulinum Toxin Type A in Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2021-02-01","conditions":"Diabetic Neuropathies","enrollment":30},{"nctId":"NCT03617367","phase":"PHASE3","title":"Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)","status":"COMPLETED","sponsor":"Revance Therapeutics, Inc.","startDate":"2018-09-05","conditions":"Cervical Dystonia","enrollment":357},{"nctId":"NCT03855046","phase":"PHASE4","title":"Complex Treatment of a Chronic Anal Fissure","status":"RECRUITING","sponsor":"State Scientific Centre of Coloproctology, Russian Federation","startDate":"2019-09-01","conditions":"Fissure in Ano","enrollment":340},{"nctId":"NCT02546999","phase":"PHASE4","title":"Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2015-09","conditions":"Cerebral Palsy, Muscle Spasticity","enrollment":61},{"nctId":"NCT03289702","phase":"PHASE3","title":"CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)","status":"COMPLETED","sponsor":"Medy-Tox","startDate":"2017-11-13","conditions":"Muscle Spasticity","enrollment":220},{"nctId":"NCT04807920","phase":"PHASE4","title":"BOTOX® at the Time of Prolapse Surgery for OAB","status":"UNKNOWN","sponsor":"Walter Reed National Military Medical Center","startDate":"2021-09-23","conditions":"Urinary Bladder, Overactive, Pelvic Organ Prolapse","enrollment":138},{"nctId":"NCT03543150","phase":"","title":"BOTOX® Drug Use Investigation (Spasmodic Dysphonia)","status":"UNKNOWN","sponsor":"GlaxoSmithKline","startDate":"2018-07-20","conditions":"Dysphonia","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["abobotulinumtoxinA","Botulinum toxin A"],"phase":"phase_3","status":"active","brandName":"Dysport Injectable Product","genericName":"Dysport Injectable Product","companyName":"Western University, Canada","companyId":"western-university-canada","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dysport is a botulinum toxin type A preparation that blocks acetylcholine release at the neuromuscular junction, causing temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Hemifacial spasm.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}